The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs: findings from a national survey in England, Wales, and Northern Ireland

Adam J W Trickey*, Sara Croxford, Eva Emanuel, Samreen Ijaz, Matt Hickman, Joanna Kesten, Clare L Thomas, C. Edmundson, Monica Desai, Peter T Vickerman

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)
88 Downloads (Pure)

Abstract

Syringes with attached needles (termed fixed low dead space syringes [LDSS]) retain less blood following injection than syringes with detachable needles, but evidence on them reducing blood borne virus transmission among people who inject drugs (PWID) is lacking. Utilising the UK Unlinked Anonymous Monitoring cross-sectional bio-behavioural surveys among PWID for 2016/18/19 (n=1429), we showed that always using fixed LDSS was associated with 76% lower likelihood (adjusted Odds Ratio=0.24, 95%CI: 0.08-0.67) of recent hepatitis C virus infection (RNA-positive and antibody-negative) among antibody-negative PWID compared to using any syringes with detachable needles.
Original languageEnglish
Article numberciac140
Pages (from-to)1073-1077
Number of pages5
JournalClinical Infectious Diseases
Volume75
Issue number6
Early online date20 Feb 2022
DOIs
Publication statusPublished - 15 Sept 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.

Keywords

  • Low dead space syringes
  • high dead space syringes
  • injecting drugs
  • IDU
  • HCV

Fingerprint

Dive into the research topics of 'The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs: findings from a national survey in England, Wales, and Northern Ireland'. Together they form a unique fingerprint.

Cite this